Autonomous Surgical Robotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Robotic Systems, Consumables, Services), By Application (Urology Surgery, Orthopedic Surgery, Cardiology Surgery, Neurology Surgery, Others), By End-User (Hospitals, Ambulatory Surgery Centers (ASCs), Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.23 Billion
CAGR (2026-2031)	12.54%
Fastest Growing Segment	Robotic Systems
Largest Market	North America
Market Size (2031)	USD 4.53 Billion

Market Overview

The Global Autonomous Surgical Robotics Market will grow from USD 2.23 Billion in 2025 to USD 4.53 Billion by 2031 at a 12.54% CAGR. The Global Autonomous Surgical Robotics Market consists of intelligent robotic systems capable of executing surgical tasks with varying degrees of independence from human operators, utilizing artificial intelligence for pre-operative planning and intra-operative guidance. The market is primarily supported by the rising incidence of chronic disorders that necessitate surgical intervention and the increasing demand for minimally invasive procedures to reduce patient recovery times. Furthermore, the global shortage of skilled medical specialists accelerates the adoption of automated technologies to augment surgical precision and efficiency. According to the International Federation of Robotics, in 2024, sales of medical robots surged by 91% to reach nearly 16,700 units globally.

However, a significant challenge impeding market expansion is the complex regulatory landscape surrounding liability and safety assurance. The transition toward autonomous decision-making raises difficult legal questions regarding accountability in the event of operational errors or adverse patient outcomes. These unresolved regulatory frameworks, combined with the substantial financial investment required for clinical validation and product certification, present a considerable barrier to the widespread commercialization and adoption of these advanced surgical innovations.

Key Market Drivers

The critical shortage of skilled surgeons and healthcare personnel is a primary catalyst accelerating the deployment of autonomous surgical robotics. As healthcare systems face a widening gap between the supply of specialized medical professionals and the volume of patients requiring complex interventions, hospitals are increasingly relying on robotic systems to augment human capabilities and streamline surgical workflows. These automated platforms reduce physical strain on operators and standardize procedure quality, effectively allowing fewer surgeons to manage higher caseloads without compromising patient safety. According to the Association of American Medical Colleges, March 2024, in the 'The Complexities of Physician Supply and Demand' report, the United States is projected to face a shortfall of up to 19,900 surgeons by 2036, highlighting the urgent necessity for technological solutions that maximize surgical throughput.

Concurrently, the rising preference for minimally invasive surgical techniques is fundamentally reshaping the market, as patients and providers seek procedures that minimize trauma and accelerate recovery. Robotic systems facilitate these delicate operations with greater precision than manual laparoscopy, driving widespread adoption across urology, gynecology, and general surgery. This demand for less invasive options is reflected in the rapid operational scaling of major industry players. According to Intuitive Surgical, October 2024, in the 'Q3 2024 Earnings Release', the company recorded an 18% increase in worldwide da Vinci procedure volume compared to the prior year, signaling robust clinical acceptance. Furthermore, emerging competitors are expanding the global footprint of these technologies; according to CMR Surgical, in 2024, the company celebrated a milestone of over 20,000 surgical cases completed globally using its Versius system, validating the expanding scope of robotic intervention.

Download Free Sample Report

Key Market Challenges

The complex regulatory landscape surrounding liability and safety assurance acts as a significant constraint on the Global Autonomous Surgical Robotics Market. As robotic systems evolve toward autonomous decision-making, existing legal frameworks struggle to clearly define accountability among human operators, medical institutions, and equipment manufacturers during adverse events. This legal ambiguity necessitates rigorous safety validation and extensive clinical trials, which significantly prolongs the product development lifecycle. Manufacturers consequently face extended timelines for regulatory approval, delaying the introduction of autonomous capabilities to the healthcare sector and creating operational uncertainty that deters potential investment.

Moreover, the financial burden associated with meeting these stringent standards hampers market expansion by raising barriers to entry for innovative developers. The substantial resources required for safety certification often divert capital away from technical research, limiting the speed of product iteration. According to MedTech Europe, in 2024, certification and maintenance costs under the new regulatory framework escalated by up to 100% compared to previous directives. This sharp increase in compliance expenditures reduces the financial viability of new ventures and slows the overall penetration of autonomous technologies in the surgical market.

Key Market Trends

The Integration of Artificial Intelligence for Real-Time Decision Support is fundamentally altering the surgical landscape by transforming robotic systems into intelligent, data-driven partners. Industry leaders are aggressively expanding their digital ecosystems to embed machine learning algorithms that provide intraoperative guidance, analyze surgical video, and optimize procedural workflows in real-time. This technological evolution allows for the predictive identification of critical anatomy and the standardization of surgical techniques, significantly reducing variability in patient outcomes. According to Medtronic, September 2025, in the 'Medtronic Announces Global Hub for AI and Robotics in Surgery' press release, the company doubled its London-based digital workforce to over 200 specialists specifically to accelerate the development of these advanced AI and digital capabilities for its robotic portfolio.

Concurrently, the Proliferation of Single-Port and Multi-Port Robotic Platforms is diversifying the market to address a wider range of clinical indications and hospital environments. Manufacturers are moving beyond one-size-fits-all solutions by launching specialized systems, such as single-port platforms for deep-access surgery and high-performance multi-port systems designed for complex general procedures. This strategic segmentation enables healthcare facilities to adopt technology that precisely matches their case mix, driving broader utilization across various surgical disciplines. According to Intuitive Surgical, January 2025, in the 'Annual Report 2024', the company successfully placed 362 units of its new da Vinci 5 multiport system globally during the year, validating the rapid clinical demand for next-generation robotic architectures.

Segmental Insights

The Robotic Systems segment is positioned as the fastest-growing category within the Global Autonomous Surgical Robotics Market, primarily driven by the introduction of next-generation platforms that integrate artificial intelligence and machine learning. These technological advancements enable systems to perform complex surgical tasks with unprecedented precision and reduced human intervention, directly addressing the demand for consistent clinical outcomes. Furthermore, the increasing frequency of product clearances by regulatory bodies, such as the U.S. Food and Drug Administration, is accelerating the installation of these units in hospitals. Healthcare providers are heavily investing in these automated solutions to enhance minimally invasive capabilities and minimize surgeon fatigue.

Regional Insights

North America holds a dominant position in the global autonomous surgical robotics market, primarily driven by substantial healthcare expenditure and the early adoption of automated medical technologies. The region benefits from a well-established healthcare infrastructure and the strong presence of key industry manufacturers, which facilitates rapid product availability. Additionally, a favorable regulatory environment, characterized by consistent clearances from the U.S. Food and Drug Administration (FDA), encourages the integration of robotic systems into clinical practice. Comprehensive reimbursement policies for robotic-assisted procedures further incentivize hospitals to invest in these technologies, sustaining regional market leadership.

Recent Developments

• In July 2025, Moon Surgical obtained 510(k) clearance from the U.S. Food and Drug Administration for significant updates to its Maestro System, including a Predetermined Change Control Plan for its AI-powered ScoPilot. This regulatory approval allows the company to efficiently implement evolving artificial intelligence algorithms for ScoPilot, which provides autonomous control of the laparoscope during procedures. Additionally, the clearance enabled active connectivity for the platform to exchange data with the cloud-based Maestro Insights tool. These developments are engineered to enhance operating room efficiency by offering surgeons greater independence and providing healthcare teams with actionable, data-driven performance metrics.
• In August 2024, Karl Storz Endoscopy-America completed the acquisition of Asensus Surgical, integrating the digital surgery company as a wholly-owned subsidiary. This transaction followed a definitive merger agreement aimed at enhancing the acquiring company's position in the robotic surgical market. The acquisition focuses on leveraging the Intelligent Surgical Unit and accelerating the development of the next-generation LUNA surgical system, which utilizes machine learning to provide intraoperative augmented intelligence. The strategic combination aims to deliver safer and more predictable surgical outcomes by merging precise robotic hardware with advanced digital analytics and AI-driven tools.
• In March 2024, Intuitive Surgical received 510(k) clearance from the U.S. Food and Drug Administration for the da Vinci 5, its fifth-generation robotic surgical system. The new platform introduces Force Feedback technology, a breakthrough feature that allows surgeons to feel subtle forces exerted on tissue, aiming to reduce trauma during operations. The system also boasts significantly increased computing power, enhanced ergonomics, and a high-resolution 3D display system. These advancements are designed to improve surgeon autonomy and streamline operating room workflows by integrating data-driven insights and advanced digital capabilities directly into the surgical console.
• In February 2024, Medical Microinstruments (MMI) secured $110 million in Series C financing to accelerate the global commercialization of its Symani Surgical System. The funding round was led by Fidelity Management & Research Company and supported by existing investors. This capital injection is intended to facilitate the expansion of the company's robotic technology into high-growth markets and fund clinical studies to broaden approved indications. The Symani system, known for featuring the world's smallest wristed microinstruments, is designed to enable precise robotic assistance during complex open soft-tissue procedures, such as lymphatic surgery and free flap reconstruction.

Key Market Players

• Medtronic plc
• PROCEPT BioRobotics Corporation
• Renishaw plc
• Surgical Automations, Inc.
• Veebot Systems, Inc.
• Zimmer Biomet Holdings, Inc.
• Venus Concept Inc.
• Stryker Corporation
• Globus Medical, Inc.
• Curexo, Inc.

By Product Type	By Application	By End-User	By Region
Robotic Systems Consumables Services	Urology Surgery Orthopedic Surgery Cardiology Surgery Neurology Surgery Others	Hospitals Ambulatory Surgery Centers (ASCs) Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Autonomous Surgical Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Autonomous Surgical Robotics Market, By Product Type:

• Robotic Systems
• Consumables
• Services

• Autonomous Surgical Robotics Market, By Application:

• Urology Surgery
• Orthopedic Surgery
• Cardiology Surgery
• Neurology Surgery
• Others

• Autonomous Surgical Robotics Market, By End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

• Autonomous Surgical Robotics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE